Gaia Herbs is leveraging their role as a leading herbal supplement company to call attention to the importance of quality, transparency, and traceability standards by issuing an open invitation to the Food and Drug Administration. Industry watch-dogs and federal regulators play essential roles in protecting consumers, and Gaia Herbs has always respected and welcomed the role of external auditing in ensuring compliance. Gaia Herbs is confident in how quality is built into all our business operations, demonstrated in our ISO-certified laboratory, our Regenerative Organic Certified® farm, and B-Corporation Certification®. While the FDA has certainly visited Gaia Herbs before, this invitation is extended in an effort to raise industry and consumer awareness of the company’s dedicated people, rigorous processes, with a goal of elevating these stringent standards across the supplement industry.
The FDA invitation, developed by Gaia Herbs’ strategic advertising and marketing agency partner Baldwin&, pulls back the curtain on Gaia Herbs’ seed to bottle practices. The campaign will launch with a full page ad in the New York Times, a :60 video invitation, and organic and paid social content featuring the Gaia Farm, onsite laboratories for testing the potency and integrity of herbs used in Gaia Herbs products, and the manufacturing facility where they are converted into their many formats – liquid extracts, functional powders, teas, Liquid Phyto-Caps™, and powder capsules. The goal of the campaign is to highlight the product integrity and manufacturing transparency that sets Gaia Herbs apart from other brands in the industry, and to prompt consumer awareness of an industry conversation about current supplement regulations while challenging higher standards across the board.
